Blog
Real-world evidence on heart failure from GLP-1 and advanced CKD populations
Early uptake of oral semaglutide for obesity (Wegovy pill) following FDA approval
Use of GLP-1 RAs following label expansion for patients with CVD and overweight or obesity
Hematologic oncology at scale: From population insight to patient-level risk signals
Evaluating changes in lidocaine and opioid administration on the day of IUD insertion, 2018-2025
Truveta experts: What adolescent sleep disorders reveal about mental health trends
Real-world survival outcomes after cardiac contractility modulation: New research from Impulse Dynamics
